Nuventra’s 10 Best Blogs of 2020

Nuventra exists to bring new medicines to patients – by being the strategic provider of clinical pharmacology science and services. 2020 was an unprecedented year for drug development and the world at large.

We are proud to have worked on more than ten COVID-19 related programs by helping our clients develop treatments and vaccines for the novel coronavirus. Our scientists are optimistic about 2021 and look forward to writing about a range of topics next year.

Our blog covers topics ranging from best practices in clinical pharmacology to emerging strategies supported by the FDA and more. Each year, we create a compilation of our 10 best blogs for our readers.

In 2021, we plan to continue our bi-monthly blog posting. To stay up to date, be sure to subscribe to our email updates. If you have any questions about the content in this packet, please feel free to reach out to our team at

Download your copy of Nuventra’s 10 Best Blogs of 2020.



Explore Our Blog

Understanding Current and Future Therapeutic Options for COVID-19

In recent weeks, the world has welcomed very positive and much anticipated news on the COVID-19 vaccine front. At least…

Read More

Fostering Inclusion and Diversity in Clinical Trials

Inaccessibility, inadequate engagement, and lack of trust—these are just some of the issues that limit inclusion and lead to a…

Read More

Comparing the FDA’s Pharmacogenomic Biomarkers and Pharmacogenetic Associations Tables

Pharmacogenomics (PGx), which considers the relationship between an individual’s genetics and their response to medications (i.e., drug-gene interactions), is expanding…

Read More